H. CON. RES. 33 - Expressing support for access to medication abortion in the United States
This bill is a resolution expressing support for access to medication abortion in the United States. It was submitted by Mr. G. Ottheimer, Ms. C. Rockett, and Ms. C. Craig and referred to the Committee on Energy and Commerce and the Committee on the Judiciary for consideration.
The resolution states that all people have a fundamental right to make personal, private health care decisions about their own bodies, lives, and futures. It supports access to medication abortion, which is considered essential for protecting this fundamental right. The resolution also emphasizes that access to medication abortion does not violate Federal law, as confirmed by a memo from the Department of Justice in December 2022.
The resolution highlights that telehealth services for medication abortion are safe and improve the accessibility of reproductive health care services. It also acknowledges that the drug mifepristone, used in medication abortion, was appropriately approved under federal law.
The resolution is titled the "Freedom to Decide Act" and its purpose is to affirm the existing authority to distribute medication abortion under federal law and to condemn restrictions on access to and coverage of reproductive health care, including medication abortion with drugs like mifepristone.